Next Science reported a 2.9% revenue increase to US$22.8 million in FY24, driven by an 85% surge in XPERIENCE™ sales, while achieving adjusted EBITDA and cashflow positivity in 4Q FY24 amid strategic cost restructuring.
Victor Sage
23 Jan 2025
Subscribe to Updates
Get moves for NXS direct to your inbox.
You're on the list!
We'll ping you the moment NXS makes a move.
Until then, follow us on socials.
Join 1000's of market focused, signal seeking investors. Unsubscribe anytime. We don't sell your data.